Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $33.3 million.

  • Cellebrite DI's Cash from Operations fell 2011.52% to $33.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.7 million, marking a year-over-year increase of 3877.78%. This contributed to the annual value of $132.2 million for FY2024, which is 2950.58% up from last year.
  • As of Q3 2025, Cellebrite DI's Cash from Operations stood at $33.3 million, which was down 2011.52% from $32.6 million recorded in Q2 2025.
  • Cellebrite DI's Cash from Operations' 5-year high stood at $66.0 million during Q4 2024, with a 5-year trough of -$10.5 million in Q1 2022.
  • Moreover, its 5-year median value for Cash from Operations was $16.6 million (2023), whereas its average is $19.9 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 839758.06% in 2022, then surged by 534784.17% in 2023.
  • Over the past 5 years, Cellebrite DI's Cash from Operations (Quarter) stood at $29.8 million in 2021, then increased by 19.98% to $35.7 million in 2022, then rose by 22.62% to $43.8 million in 2023, then surged by 50.51% to $66.0 million in 2024, then crashed by 49.56% to $33.3 million in 2025.
  • Its last three reported values are $33.3 million in Q3 2025, $32.6 million for Q2 2025, and $20.9 million during Q1 2025.